AbbVie Raises Profit Forecast Despite Tariff Concerns
Pharmaceutical giant AbbVie has raised its full-year profit forecast, citing strong sales of its newer immunology drugs. The company’s updated 2025 forecast ranges between $12.09 and $12.29 per share, a 10-cent increase from the previous estimate. AbbVie’s shares have fallen over the past month due to concerns about a probe into pharmaceutical imports that could … Read more